DRMA
Dermata Therapeutics Inc
NASDAQ: DRMA · HEALTHCARE · BIOTECHNOLOGY
$1.37
+8.73% today
Updated 2026-04-30
Market cap
$4.99M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.16
Dividend yield
—
52W range
$1 – $10
Volume
1.8M
Dermata Therapeutics Inc (DRMA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-194.20%
ROA
-85.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-4.72M | — | — | — |
| 2020 | $0.00 | $-3.24M | — | — | — |
| 2021 | $0.00 | $-7.95M | — | — | — |
| 2022 | $0.00 | $-9.61M | — | — | — |
| 2023 | $0.00 | $-7.79M | — | — | — |
| 2024 | $0.00 | $-12.29M | — | — | — |
| 2025 | $0.00 | $-7.56M | — | — | — |